OOIR: Observatory of International Research

Papers

(The H4-Index of Headache is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Post‐traumatic headache: An unmet medical need	451
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	78
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	72
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	67
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	65
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	64
Erratum	60
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	57
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	53
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	51
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	50
Migraine screening in English and Spanish	46
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	42
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	42
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	42
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	38
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	35
Migraine and peripheral pain models show differential alterations in neuronal complexity	34
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	33
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code	32
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	31
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	30
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	29
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	28
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	27

Telehealth as a new care delivery model: The headache provider experience	27
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	27